SCHEMBL8053641

SCHEMBL8053641

NCc1cncc(CF)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 9/20 0.37
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
CYP2A6 P11509 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRR1 P24046 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRB2 P47870 1/20 0.31
LOX P28300 2/20 0.31
CYP11B2 P19099 1/20 0.31
ASIC3 Q9UHC3 1/20 0.31
AOC1 P19801 1/20 0.30
AOC3 Q16853 1/20 0.30
LOXL3 P58215 1/20 0.30
CHRNA7 P36544 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8048996 0.87 LOXL2 (0.46) LOXL2CHRNB2CHRNA4NOS1NOS2
SCHEMBL3350229 0.76 LOXL2 (0.39) LOXL2NOS1NOS2LOX
SCHEMBL30095912 0.76 SMYD3 (0.41) LOXL2CHRNB2CHRNA4NOS1NOS2
SCHEMBL12844600 0.76
SCHEMBL7288743 0.76
SCHEMBL164566 0.76
SCHEMBL30831319 0.73
SCHEMBL17959496 0.73
SCHEMBL25273562 0.71
SCHEMBL3732090 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589085-B2 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity MERCK & CO., INC. (US) 2009-09-15 US disclosed
WO-2009042694-A1 (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING COMENTIS, INC. (US) 2009-04-02 WO disclosed
WO-2009015369-A2 COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2009-01-29 WO disclosed